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Abstract A multi-mycotoxin immunoassay—using the
MultiAnalyte Profiling (xMAP) technology—is developed
and evaluated. This technology combines a unique color-
coded microsphere suspension array, with a dedicated flow
cytometer. We aimed for the combined detection of
aflatoxins, ochratoxin A, deoxynivalenol, fumonisins, zear-
alenone and T-2-toxin in an inhibition immunoassay
format. Sets of six mycotoxin-protein conjugates and six
specific monoclonal antibodies were selected, and we
observed good sensitivities and no cross-interactions
between the assays in buffer. However, detrimental effects
of the feed extract on the sensitivities and in some cases on
the slopes of the curves were observed and different sample
materials showed different effects. Therefore, for quantita-
tive analysis, this assay depends on calibration curves in
blank matrix extracts or on the use of a suitable multi-
mycotoxin cleanup. To test if the method was suitable for
the qualitative detection at EU guidance levels, we fortified
rapeseed meal, a feed ingredient, with the six mycotoxins,
and all extracts showed inhibited responses in comparison
with the non-fortified sample extract. Contaminated FAPAS
reference feed samples assigned for a single mycotoxin
showed strong inhibitions in the corresponding assays but
also often in other assays of the multiplex. In most cases,
the presence of these other mycotoxins was confirmed by
instrumental analysis. The multiplex immunoassay can be
easily extended with other mycotoxins of interest, but
finding a suitable multi-mycotoxin cleanup will improve its
applicability.
Keywords Multiplex.Immunoassay.Flow cytometer.
Microspheres.Mycotoxins.Feed
Introduction
Mycotoxins are secondary metabolites produced by fungi
and often co-occur. Their presence in food and feed are
serious threats to the health of humans and animals and
monitoring is vital. The most common assayed mycotoxins
are aflatoxins (AFs), ochratoxin A (OTA), deoxynivalenol
(DON), fumonisins (F), zearalenone (ZEA) and T-2-toxin
(T-2). Many methods are available for the detection of
mycotoxins and, mainly, they can be divided into
immunochemistry- and chromatography-based techniques,
with enzyme-linked immunosorbent assay (ELISA) and
liquid chromatography combined with mass spectrometry
(LC-MS/MS) being the most popular. For the execution of
legal tasks, often requiring high specificity, accuracy,
sensitivity and good reproducibility, mycotoxins are fre-
quently determined by LC-MS/MS. The simultaneous
detection of several mycotoxins is a major advantage of
this technique. Recently, a multi-mycotoxin LC-MS/MS-
based method for the simultaneous detection of 23
mycotoxins was described (Monbaliu et al. 2009). However,
this technique is less suitable for rapid and high throughput
testing. It needs skilled personnel to handle the sophisticated
machines and often requires sample cleanup, by the use of
immunoaffinity (for specific mycotoxins) or solid phase
extraction columns (Krska et al. 2008). Therefore, LC-MS/
MS methods are laborious and time-consuming and less
practical for on-site testing.
Nowadays, ELISA is the most common immunoassay
format used. ELISA test kits for the detection of the major
mycotoxins are widely available on the market (Goryacheva
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DOI 10.1007/s12550-010-0077-0et al. 2007). They allow easy and fast quantitative detection
with good sensitivities and are suitable for the high
throughput screening of samples and for on-site testing. For
some sample materials, additional sample cleanup is neces-
sary to avoid under or overestimates by disturbing matrix
effects (Zheng et al. 2006). Other low-cost rapid immuno-
assay formats used are strip tests (Shim et al. 2009)a n d
fluorescence polarization (Maragos 2009). A major disad-
vantage of these rapid immunoassay formats is that they are
not suitable for the simultaneous detection of several
mycotoxins, although a duplex strip test (Shim et al. 2009)
and a duplex microarray assay (Lamberti et al. 2009)h a v e
recently been described.
A new platform for robust multiplexed immunochemical
detection is the MultiAnalyte Profiling (xMAP) technology
from Luminex (Austin, TX, USA). It is an emerging
technology that uses small carboxylated polystyrene micro-
spheres which are internally dyed with a red and an infrared
fluorophore (Dunbar et al. 2003). By varying the ratio of
the two fluorophores, up to 100 different color-coded
microsphere sets can be distinguished, and each micro-
sphere set can be coupled with a different biological probe.
The microspheres are detected and characterized by a
dedicated flow cytometer (Early et al. 2002), using a red
laser (635 nm) for excitation and emission wavelengths are
measured between 645 and 669 nm and >712 nm. After the
microspheres are classified, the reporter signal is measured.
The general reporter molecule used is R-Phycoerythrin
(R-PE) which is excited by a green laser (532 nm) and the
emission is measured at 580 nm (Peters et al. 2007). This
creates the possibility to simultaneously measure up to 100
different biomolecular interactions in a single well.
There are different types of microspheres available such
as the xTAG
® microspheres for DNA purposes, the
generally used MicroPlex
® and the SeroMap™ micro-
spheres with altered surface for problematic assays. All
these varieties have a size of 5.6 μm. The superparamag-
netic MagPlex® microspheres (6.5 μm) used in this
research are available in 80 unique colour codes. Scattered
over the microsphere there are magnetite particles for
response to a magnetic field which simplifies the work
with food or feed samples.
The microspheres can be coupled with a wide range of
biomolecules like nucleotides, peptides, proteins, antibodies,
receptors, polysaccharides and lipids (Kellar and Ianonne
2002). The xMAP technology is already used in many fields
and the number of applications is growing rapidly (http://
www.luminexcorp.com/bibliography, 2010). The main
xMAP applications are dedicated kits for medical testing
like respiratory viruses, cytokine profiling, and neonatal
screening (http://www.luminexcorp.com/products/assays/
overview.html, 2010). However, the xMAP technology also
allows you to develop your own customized assays. This has
already been done in the field of nucleic acids (Dunbar
2006), food proteins (Haasnoot and du Pré 2007), antibiotics
(de Keizer et al. 2008) and polycyclic aromatic hydrocarbons
(Meimaridou et al. 2010), and whole bacteria (Peters et al.
2007) and plant viruses (Bergervoet et al. 2008)h a v ea l s o
been assayed using this technology. More recently, an xMAP
duplex immunoassay has been developed for the detection of
the mycotoxins OTA and fumonisin B1 (FB1)i ng r a i n
products (Anderson et al. 2010). In other assays, the xMAP
technology proved to be as sensitive as ELISA in compar-
ative testing and is less labor-intensive and reduces costs
(Biagini et al. 2003)
In our multi-mycotoxin flow cytometric immunoassay
xMAP approach, mycotoxin-BSA conjugates of aflatoxin
B1 (AFB1), OTA, FB1, DON, ZEA and T-2 Toxin (T-2) are
coupled to the carboxylated paramagnetic microspheres.
These six coupled microspheres and all six specific
monoclonal antibodies (Mabs) against the same toxins are
added to the sample. The free mycotoxins from the
standards and/or sample extracts will inhibit the binding
of the Mabs to the mycotoxin-BSA conjugates on the
microspheres. After a magnetic capturing step, a secondary
anti-mouse antibody coupled with R-PE is added as a
detection molecule. This mixture containing six different
microspheres will eventually pass through the flow cell and,
upon laser illumination, the microspheres will be classified
and its mean surface reporter signals (mean fluorescence
intensities; MFIs) will be quantified.
After extensive testing for optimum dilutions/responses,
sensitivity, specificity and cross-interactions, six Mabs were
selected for this multiplex assay. We tested calibration
curves for each mycotoxin in buffer and in an extract of a
“blank” rapeseed meal (a feed ingredient). To see if the
assay was able to perform at the EU guidance levels for
feed, we fortified rapeseed meal with the pure mycotoxins
prior to sample extraction. Other sample materials (feed and
some feed ingredients) were also tested for their matrix
influence on the multiplex assay. Finally, contaminated
FAPAS reference feed samples were tested and the results
were compared with instrumental analysis data.
Materials and methods
Instrumentation
The xMAP assay measurements were carried out on a
Luminex 100 IS 2.2 system, consisting of a Luminex 100
analyzer, a Luminex sheath delivery system and a Luminex
XY Platform, which is programmed to position a 96-well
plate, using StarStation System software from Applied
Cytometry Systems (ACS, Dinnington, Sheffield, UK). All
washing steps were carried out on a Bio-Plex™ Pro II Wash
64 Mycotox Res (2011) 27:63–72Station (Bio-Rad Laboratories, Veenendaal, the Netherlands)
using a magnetic plate carrier. Plates were incubated on a
Dynatech microtiter vari-shaker (Alexandria, VI, USA).
During the coupling procedures, the paramagnetic micro-
spheres were captured using the DynaMag-2™ magnet stand
(Invitrogen Dynal, Oslo, Norway). Mixing for sample
extraction was done in a REAX2 end-over-end shaker
(Heidolph, Schwabach, Germany). All centrifuge steps were
done in an Eppendorf 5810 R centrifuge using the A-4-62
rotor (VWR International, Amsterdam, the Netherlands).
Materials, reagents and standards
MagPlex microsphere sets with numbers 036, 038, 054,
086, 090, 100 and Sheath Fluid were purchased from
Luminex. Monoclonal antibodies (Mabs) against AFB1
(6G4), FB1 (1D6), OTA (5E2), ZEA (88) and T2 (8H2)
were obtained from Soft Flow Biotechnology (Gödöllö,
Hungary) and against DON (AB0222) from Aokin
(Berlin, Germany). From Sigma-Aldrich (Zwijndrecht, the
Netherlands), the AFB1-BSA conjugate (A6655), 1-ethyl-3-
[3-dimethylamino-propyl]carbodiimide hydrochloride
(EDC), N-hydroxysulfosuccinimide (Sulfo-NHS), 2-(N-
morpholino)ethanesulfonic acid (MES) and BSA were pur-
chased. FB1-BSA was a kind gift from Jules Beekwilder of
Plant Research International (Wageningen, the Netherlands).
BSA conjugates of OTA (CON003), DON (CON002), ZEA
(CON005) and T-2 (CON004) were from Biopure (Tulln,
Austria) as well as the solid standards of the mycotoxins
AFB1,O T A ,D O N ,Z E A ,F B 1 and T-2. Goat anti-mouse
IgG-R-Phycoerythrin conjugate was obtained from Prozyme
(Hayward, CA, USA). Skimmed milk powder (blotting
grade blocker, non-fat dry milk) was from Bio-Rad
Laboratories. Acetonitril was purchased from Biosolve
(Valkenswaard, the Netherlands). Greiner Cellstar 96-well
microtiter plates were used for all assays. All other chemicals
were ordered from VWR. The “blank” rapeseed meal and
other sample materials were supplied previously to and
analyzed by RIKILT. Reference feed samples were ordered
from FAPAS
® (York, UK).
Coupling of mycotoxin-BSA conjugates
to the microspheres
Each microsphere stock suspension (1.25×10
7 micro-
spheres/ml) was vortexed vigorously for 5 min. From each
stock, 500 μl (approximately 6 million microspheres) was
taken and transferred to an Eppendorf tube. This tube was
placed in the magnetic stand and beads were allowed to
settle for 5 min. The supernatant was removed and 500 μl
of 100 mM monobasic sodium phosphate pH 6.2 was
added with the tube still in the magnetic stand. After 2 min
of settling, the supernatant was removed again and the
microspheres were resuspended in 80 μl of the same
sodium phosphate buffer. To this microsphere suspension,
10 μl of 50 mg/ml Sulfo-NHS and 10 μl of 50 mg/ml EDC
were added. The suspension was incubated in the dark at
room temperature for 20 min. During this incubation, the
microsphere suspension was mildly vortexed every 5 min.
After incubation, the tube was placed in the magnetic stand
and microspheres were allowed to settle for 1 min. The
supernatant was removed and the microspheres resus-
pended in 250 μl of 50 mM MES buffer pH 5.0 by
pipetting up and down several times. The microspheres
were captured again and the washing step with the same
MES buffer was repeated. A previously prepared 500-μl
solution of the mycotoxin-BSA conjugate at a concentra-
tion of 125 μg/ml in MES was then added to the
microspheres. This suspension was incubated for 2 h in
the dark at room temperature while gently rotating. The
microspheres were captured and washed 2 times with 500 μl
PBS-TBN (Phosphate Buffered Saline containing 0.1% BSA,
0.02% Tween-20 and 0.05% sodium azide, pH 7.4). For
storage, the microspheres were resuspended in 500 μlo ft h e
same PBS-TBN. After overnight storage at 4°C, the micro-
spheres were ready for use in the assays. The final concen-
trationsofthemicrosphereswere determined inthe Luminex by
counting diluted portions for 60 s with a flow rate of 60 μl/min.
The xMAP immunoassay
Mycotoxin standard stock solutions were prepared in an
acetonitrile/water mixture (80:20; v/v) at concentrations of
100–200 μg/ml. For the calibration curves, necessary
standard solutions were prepared from these stock solutions
by serial dilutions in water.
For the xMAP assay, 40 μl of standard solution or
standard solution mixed (1:1; v/v) with sample extract (in
the case of dose-response curves in sample extract) or 2
times in water-diluted sample extract was added to each
well of a microtiter plate. Subsequently, 10 μl of concen-
trated PBM (5 times concentrated PBS containing 1% of
skimmed milk powder) containing the Mabs of choice were
added and incubated for 10 min on a shaker at room
temperature. During the initial testing, each antibody was
tested separately to check for cross-interactions. After this,
the 6 microspheres sets coupled with different mycotoxins,
around 1,000 microspheres of each set, were added in 10 μl
of PBM and the assay was incubated for another 30 min at
room temperature. The plate was then transferred to the
washer for a total of 3 washing steps with PBS. The
remaining volume after washing was approximately 30 μl.
To each well, 70 μl of R-PE conjugated goat anti-mouse
antibody (2.85 μg/ml in PBS) was added and the micro-
spheres were brought back in suspension by pipetting up
and down. The samples were incubated while shaking for
Mycotox Res (2011) 27:63–72 6515 min. After incubation, the plate was again transferred to
the washer for one final washing step with PBS. To each
well, 70 μl of PBS was added and the microspheres were
resuspended by pipetting up and down. The samples were
measured in the Luminex analyzer for a total of 100
microspheres per set per sample with an average of 45 min
for the measurement of a 96-well plate. During the
measurement, the Luminex uses four detectors [three
avalanche photodiodes (APDs) and one photomultiplier
tube (PMT)]. Two APDs are used for the classification of
the beads by measuring the emission signals (between 645
and 669 nm and >712 nm) from the two internal dyes
excited by a red laser diode (633 nm). As shown in Fig. 1
(upper right part), the 6 microsphere sets are classified in
the classifier plot. This laser diode is also used for the
determination of side scatter signals of all the measured
microspheres which correlates to the particle size. This side
scatter signal is detected by the third APD, presented in the
discriminator plot (Fig. 1, upper left part) and represents
the total measured events. The PMT is used to measure the
microsphere-bound reporter molecules after the excitation
by a green laser (532 nm), and examples of the reporter
signals are shown in Fig. 1 (the lower two parts) for the
DON and ZEA assays in the multiplex format. The
software calculates the median reporter signal for each
measurement.
LC-MS/MS multi-mycotoxin method
The amounts of the mycotoxins DON, FB1, T-2, HT-2,
OTA, ZEA and in some cases AFB1 were determined using
an in-house validated and accredited LC-MS/MS based
method. In short, 2.5 g of sample material was extracted
with 10.0 ml of extraction solvent (acetonitril/water/formic
acid: 84/16/1; v/v/v). The mixture was shaken for 2 h and
then centrifuged. The supernatant was diluted with water
(1:1), and filtered prior to LC-MS/MS analysis with 5-μl
injections and eluted using a water (eluent A)/95%
methanol/water (v/v) (eluent B) gradient, both containing
1 mM ammonium formate and 0.53 mM formic acid, at a
column temperature of 35°C. The LC-MS/MS system con-
sisted of a Shimadzu Prominence system, a Phenomenex
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Fig. 1 Typical flow cytometric
output of the StarStation soft-
ware showing all microspheres
in the Doublet Discriminator
(DD) plot (upper left part),
classification and counting of
the microspheres based on the
log CL1 (red) and log CL2
(infra-red) ratio in the Classifier
plot (upper right part) and 2 of
the 6 response plots (lower two
parts) showing the reporter
signals (RPTs) for the DON and
ZEA assay in the multiplex flow
cytometric immunoassay
66 Mycotox Res (2011) 27:63–72Synergi 4 μ Hydro RP UPLC column (150 mm × 2 mm,
2.5 μm) and an AB SCIEX QTRAP
® used in MS/MS-mode.
The mycotoxin content was quantified with a standard
addition procedure.
Fluorescent-HPLC (F-HPLC) AFB1 detection
The AFB1 content for some samples was previously
determined in proficiency testing using an in-house
validated and accredited HPLC-fluorescence-based method.
In short, 20 g of sample material, 10 g of celite, 10 ml of
water and 100 ml of chloroform were mixed for 30 min.
After filtration, 2.0 ml of extract was evaporated until
dryness. The residue was dissolved in 1.0 ml of methanol
and the solution was diluted with 9.0 ml of water. The
resulting solution was cleaned with Immuno Affinity
Cleanup (IAC). The Fluorescent-HPLC system consisted
of a Gilson pump and autoinjector, a Jasco fluorescence
detector and a KOBRA-cell equipped with a Waters
Symmetry C18 HPLC column (150×3.0 mm, 5 μm).
For analysis, 100-μl extracts or reference solutions were
injected and eluted using a water/methanol/acetonitril eluent
(130/70/40; v/v/v) containing 1 mM KBr and 1 mM HNO3.
Quantitative analysis was performed by calculation versus a
calibration curve.
Extraction of feed matrix
Sample extraction was performed according to an in-house LC-
MS/MS protocol that was in use for the simultaneous detection
of several mycotoxins. For each sample, 2 times 2.5 g was
w e i g h e da n dt r a n s f e r r e dt oa5 0 - m l tube. To the first tube, 10 ml
of double distilled water was added. To the second tube, 10 ml
of acetonitril/water (84/16; v/v) mixture was added. Both tubes
w e r et h e ni n c u b a t e df o r2ha tr oom temperature while gentle
mixing using an end-over-end shaker. The tubes were
centrifuged at room temperature for 10 min at 2,000g using a
swinging bucket rotor. The supernatants were combined in
equal volumes and incubated for 1 h at 4°C. After incubation,
the mixed sample extracts were again centrifuged at the same
speed. The supernatant was diluted twice and used directly in
the assays. The dose-response curves were made with
standard solutions diluted in water (see “The xMAP
immunoassay”) but also with mixtures (1:1; v/v) of the
standard solutions and “blank” sample extract.
Results and discussion
Immunoassays for low molecular weight compounds use
the direct (antibody-coated surfaces) or indirect (hapten-
coated surfaces) competitive or inhibition assay formats.
We have chosen for the indirect inhibition assay format in
which the binding of the Mabs to the mycotoxin-coated
microspheres is inhibited by the mycotoxins in solution.
For the coupling of proteins to the xMAP microspheres,
standard protocols are available (Luminex) and, therefore,
BSA was used as the carrier protein for the mycotoxins
during the microsphere coupling. The final selection of
mycotoxin conjugates and Mabs was compiled after a
previously performed large-scale screening of reagents
obtained from different suppliers (data not shown) and
was based on maximum responses, sensitivities of the dose-
response curves, specificities (cross-reactions with other
mycotoxins), and cross-interactions between the assays.
The optimal coupling concentration for the mycotoxin–
BSA conjugates to the microspheres proved to be
125 μg/ml. The addition of mycotoxin-specific Mabs, at
optimized dilutions, and a secondary anti-mouse R-PE
reporter antibody showed significant fluorescence
responses for each mycotoxin-coupled microsphere set
ranging from 3,000 to roughly 6,000 MFI in buffer (Table 1).
The Mab stock solutions (1 mg/ml) were diluted from 600 to
30,000 times, resulting in final concentrations in the assay of
1.6 μg/ml for anti-AFB1 and anti-FB1,0 . 8 3μg/ml for anti-
OTA, 0.67 μg/ml for anti-ZEA, 0.17 μg/ml for anti-DON,
and 0.03 μg/ml for anti-T-2. The observed differences of
signals depend on the coupling efficiencies of the mycotoxins
to BSA and of the conjugates to the microspheres (influenced
by the remaining free amino groups on the conjugates and the
Antibody Maximum responses (MFI) per assay
a
AFB1 OTA ZEA DON FB1 T-2
Mixed
b 7,200±100 4,600±200 4,600±200 8,200±100 4,500±200 4,600±200
Anti-AFB1 5,000±200 9 21 25 35 5
Anti-OTA 1 3,500±200 25 27 31 7
Anti-ZEA 13 15 5,800±300 33 25 3
Anti-DON 1 13 19 5,300±300 27 11
Anti-FB1 5 7 29 27 3,200±200 7
Anti-T2 3 7 23 27 27 3,100±100
Table 1 Average (n=2)
maximum responses (MFI)
obtained with the multiplex
flow cytometric immunoassay
in buffer, using the individual
and the mixed antibodies
aAll data were obtained in
multiplex microsphere setting
bA mixture of the six Mabs
Mycotox Res (2011) 27:63–72 67polar changes of the protein surface by the mycotoxin
molecules) and on the dilutions and affinities of the different
Mabs. All the individualmycotoxin-specificMabsweretested
with the complete mixture of six mycotoxin-specific micro-
sphere sets to see whether cross-interactions between the
assays could be observed. Table 1 shows that the final
selection of reagents did not show any remarkable cross-
interactions between the assays. However, except for the
ZEA assay, the responses for each specific microsphere set
increased when all six antibodies were used simultaneously
(mixed) in the multiplex assay. It seems that the presence of
higher concentrations of antibodies increase the responses,
probably due to the non-specific binding of antibodies to
each other in the multiplex assay. Fortunately, this presumed
non-specific binding had no negative effects on the dose-
response curves because full inhibitions were still obtained
(Fig. 2a). The dose-response curves in buffer, measured in
triplicate over a 3-day period, showed good sensitivities for
all mycotoxins when measured in multiplex setting (Fig. 2a).
The concentrations at 50% relative response [or at 50%
inhibition (IC50 values)] of the dose-response curves in the
different assays, were 0.29, 0.33, 0.39, 1.6, 2.2 and 6.7 ng/ml
for OTA, AFB1,Z E A ,F B 1, T-2, and DON, respectively.
Compared to the ELISA data supplied by the manufac-
turers, the IC50 values of the multiplex for OTA, ZEA and
T-2 were comparable and were two and three times lower
for FB1 and DON, respectively, and four times higher for
AFB1. This indicates that the AFB1 assay can probably
still be improved, for instance, by modifying or changing
the buffer. The small error margins show the high
precision of the multiplex assay in buffer. Unfortunately,
the curves for AFB1, OTA, ZEA and T-2 are very steep
and therefore have limited dynamic ranges. The assays
were tested for the described mycotoxins only but will
also detect derivatives and other forms of these mycotox-
ins as shown from the manufacturer’s data sheets.
According to the suppliers specifications, the anti-AFB1
Mab was reported to have cross-reactivity with the
aflatoxins B2 (76 %), G1 (55 %) and G2 (6 %) and the
anti-FB1 M a bw i t ht h ef u m o n i s i n sB 2 (FB2,9 1% )a n dB 3
(FB3, 209 %). The anti-ZEA Mab cross-reacts with
zearalanon (138 %), α-zearalenol (91 %), β-zearalenol
(21 %), α-zearalanol (69 %) and β-zearalanol (6 %) and
the anti-T-2 Mab with acetyl-T-2 (12.3 %), HT-2 (3.4 %)
and iso-T-2 (2.5 %). The anti-OTA and anti-DON Mabs
had no reported cross-reactivities. The reported cross-
reactivities might differ per type of assay and sample
material and still need to be tested with relevant samples
in the multiplex flow cytometric final format. In general,
cross-reactivities may lead to overestimated concentra-
tions of the assayed mycotoxin. For instance, guidance
values for aflatoxins in feed are just set for AFB1 and
there is no guidance level for the total aflatoxins, as is the
case for food. This means that our assay could give
overestimated results for AFB1 due to relatively high
cross-reactivities with AFB2 and AFG1.I fc r i t i c a l ,s a m p l e s
tested positive for aflatoxins in the multiplex should
always be checked for the actual concentration of AFB1
using LC-MS/MS. Therefore, the AFB1 assay is more
qualitative than quantitative. The FB1 antibody used in the
assay has high cross-reactivities with FB2 and FB3.L i k e
in food, there are combined guidance levels for FB1 and
FB2 in feed. The concentration of FB2 in feed is normally
around 15–35% of the FB1 concentration (Hascheck et al.
2001). The high cross-reactivity for FB3 seems not to be a
major problem since it is rarely present in feed (ingre-
dients) as was shown by previous LC-MS/MS measure-
ments within our institute (data not shown). Its occurrence
seems related to the presence of high FB1 concentrations.
For ZEA, the appearance of high concentrations of its
metabolites in feed are very unlikely (Vendl et al. 2010)
and therefore will not contribute to substantial over-
estimations in this assay. In the case of T-2, the mentioned
cross-reactions with HT-2 will slightly contribute to the
total response when working with this Mab. If the
simultaneous or single detection of HT-2 is desired
another antibody is required or has to be added as a new
parameter to the assay.
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Fig. 2 Average dose-response curves (n=9) of the six mycotoxin
assays in the multiplex microsphere inhibition assay format in buffer
(a) and in two times diluted sample extract (b)
68 Mycotox Res (2011) 27:63–72In this study, a rapeseed meal was chosen as the
model “blank” feed sample material because, based on
LC-MS/MS data available within RIKILT, mycotoxin
concentrations were below the limits of detection (LODs)
of this method for feed analysis (AFB1 <0.005 mg/kg,
DON <0.50 mg/kg, FB1 <0.10 mg/kg, FB2 <0.10 mg/kg,
FB3 <0.10 mg/kg, OTA <0.025 mg/kg, T2 <0.5 mg/kg,
and ZEA <0.05 mg/kg). Therefore, it is still possible that
this “blank” feed sample contains mycotoxins at levels
below these LODs which might influence the screening
assay. Measuring dose-response curves in the rapeseed
meal extract showed significant decreases of the maximum
responses, compared to the response in buffer, for most of
the dose-response curves (up to 64%), and also had an
effect on most of their sensitivities (Fig. 2b). The
sensitivity for the DON curve was most influenced by
the addition of the sample extract, and the addition of
higher toxin concentrations will be necessary to produce a
useful dose-response curve. The use of acetonitrile at a
concentration of 14% showed no drastic influence on the
total MFI for the DON assay when used as a blank sample.
Also, for ZEA, a shift in sensitivity was observed and
some toxin concentrations showed increased error mar-
gins. Besides a negative effect on the sensitivity and
precision, the sample extract enlarged the dynamic range
for ZEA. The same effect was seen for the AFB1 curve.
The OTA curve remained largely unaffected by the
addition of sample extract. The effects on the maximum
responses by the addition of different sample materials in
the AFB1 and OTA assays are shown in Fig. 3 which
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Fig. 3 Average (n=3) maximum responses (MFI) for the OTA (a) and
AFB1 (b) assays in different sample extracts and buffer
Table 2 Average responses (MFI) obtained with the multiplex flow
cytometric immunoassay (n=3) for extracts of a “blank” rapeseed
meal fortified with mycotoxins at EU guidance levels (Directive 2002/
32/EC 7 May 2002, Commission recommendation 2006/576/EC 17
August 2006)
Mycotoxin added Level of addition (μg/kg) Responses (MFI) for each assay
AFB1 OTA ZEA DON FB1 T-2
None 0 2,100±50 2,800±100 3,600±200 980±50 1,600±50 2,000±50
AFB1
a 5 1,900±100 2,800±50 3,800±100 1,100±50 1,600±50 2,100±100
OTA
b 50 2,100±50 30±3 3,700±200 980±50 1,500±50 2,000±100
ZEA
c 100 2,200±50 2,800±100 420±20 1,000±50 1,700±50 2,100±50
DON
d 900 2,300±100 2,900±200 3,900±200 460±50 1,600±200 2,200±200
FB1
e 5,000 2,300±50 2,800±100 4,000±100 1,000±50 39±3 2,300±50
T2
f 10 2,300±100 2,900±200 3,800±200 1,100±50 1,700±100 1,400±100
Recommended guidance values of the EU:
aLowest level for feed for dairy cattle
bLowest level for feed for pigs
cLowest level for feed for young pigs
dLowest level for feed for pigs
eLowest level for FB1+FB2 in feed for pig, horses, rabbits and pets
fThe level for T2 was set at 10 µg/kg since there is no official guidance value
Mycotox Res (2011) 27:63–72 69demonstrates that the AFB1 a s s a yi sm u c hm o r es u s c e p -
tible to matrix interference than the OTA assay. Each
sample material shows a decrease of response compared to
t h er e s p o n s ei nb u f f e r .T h es a m en e g a t i v ee f f e c t sw e r e
observed for the ZEA and FB1 assays but were most
severe for the DON assay. The T-2 assay, like the OTA
assay, remained largely unaffected. Therefore, for quanti-
tative analysis, this assay depends on calibration curves in
blank matrix extracts, which is difficult because of the
varying content of feed, or on the use of a suitable multi-
mycotoxin cleanup.
To test if the method was suitable for the qualitative
detection, the “blank” rapeseed meal was fortified with the
6 mycotoxins at EU guidance levels (Directive 2002/32/EC
7 May 2002, Commission recommendation 2006/576/EC
17 August 2006). All the fortified samples showed reduced
responses (inhibition) in the specific assays when compared
to the non-fortified controls (Table 2). The samples fortified
with other mycotoxins could also be considered as negative
controls for the specific assays and all the responses in the
fortified samples were found to be significantly lower
(lower responses compared to the average responses minus
three times the SD). In the case of the OTA, FB1, ZEA and
DON assays, there are strong inhibitions of the responses
(99, 98, 89 and 56 %, respectively), but for the AFB1 assay,
and to a lesser extent the T-2 assay, there is less inhibition
(15 and 34 %, respectively) at these relevant concentra-
tions. The AFB1 assay certainly needs some improvement
which is probably best done by changing one of the two
essential reagents. For the T-2 assay, it is less urgent to
make changes. The guidance value we chose was very
stringent. For example, Liesener et al (2010) used a level of
250 μg/kg based on the comparison of the toxicity of T-2 to
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Table 3 Comparison of the average responses (MFI, n=3) obtained
with extracts of mycotoxin-spiked blank rapeseed sample (at guidance
values) and with spiked extract of the blank sample, indicating
extraction efficiencies of the different mycotoxins using the multi-
mycotoxin extraction procedure
Mycotoxin Average response (MFI) Response ratio after
and before extraction
Fortified
supernatant
a
Fortified raw
material
b
AFB1 1,976 1,890 1.04
OTA 31 39 0.79
ZEA 529 459 1.15
DON 26 30 0.87
FB1 284 418 0.68
T-2 691 1,376 0.50
aBlank rapeseed meal extract (supernatant) was fortified with the different
mycotoxins at the 100% extraction efficiency levels
bRapeseed meal was fortified before extraction at EU guidance levels
70 Mycotox Res (2011) 27:63–72DON. Furthermore, some east European countries have set
the guidance level for T-2 at 100 μg/kg. It also becomes
clear from the response ratio in Table 3 that the extraction
for T-2 is not optimal using the current protocol. This is not
the case for AFB1, the extraction of which seems to be
optimal based on that ratio.
The contaminated FAPAS reference feed samples (forti-
fied or naturally contaminated, which was not clear from
the sample information) were investigated and the average
maximum responses of the rapeseed fortified dose-response
curves were used to calculate the percentages of inhibition
(Table 4). All four samples that were assigned for the
presence of AFB1 (7–23 μg/kg) showed strong inhibitions
(90–98 %) in the AFB1 assay, but three of them also in the
ZEA assay (77–95 %) and one (T0470) in the DON assay
(64 %). With LC-MS/MS, ZEA was found in two of these
samples (52 and >200 μg/kg) and the DON sample
contained a high concentration (1440 μg/kg). The two
OTA assigned samples showed strong inhibited responses
in the OTA assay (97 and 98 %), but also in the FB1 assay
(82 and 94 %) and one (T1758) in the T2 assay (62 %).
With LC-MS/MS, FB1 was found (77 and 164 μg/kg) but
T-2 could not be detected with LC-MS/MS in that sample
because of an interfering peak. LC-MS/MS data showed a
high concentration of HT-2 in this particular sample
(430 μg/kg, data not published). The ZEA assigned sample
(T2225) showed a strong inhibition in the ZEA assay (94%)
but also in the FB1 and DON assay in which the LC-MS/
MS found a low concentration of FB1 (147 μg/kg) and a
high concentration of DON (920 μg/kg). The two DON-
assigned samples showed strong inhibited responses in the
DON assay (52 and 59 %) but with one sample (T2230)
also in the FB1 assay (97 %), in which the LC-MS/MS
found 2,880 μgo fF B 1/kg, and in the ZEA assay (40 %), in
which the LC-MS/MS found 160 μg of ZEA/kg. The other
sample(T2240) inhibitedtheT-2assay(50%),the ZEAassay
(60%)andtheFB1assay(94%)andtheLC-MS/MSfoundT-
2( 4 7μg/kg), ZEA (10 μg/kg) and FB1 (115 μg/kg). These
additional mycotoxins found in these reference feed samples,
show the potential of the multiplex screening assay.
However, one AFB1 assigned sample (T0478) also caused
strong inhibition in the OTA assay (97%) and another
(T0486) in the ZEA assay, which could not be confirmed by
LC-MS/MS.
The overall results of the qualitative multiplex immuno-
assay look promising and will be further exploited in new
research. Unfortunately, this research cannot be extended
with the same reagents, because of the discontinuation of
the supply of the mycotoxin-BSA conjugates from Biopure.
Home-made mycotoxin–protein conjugates and conjugates
from other suppliers are now under investigation in
combination with the described Mabs. The performances
of indirect and direct inhibition assays will be compared, as
well as improvements in the assay’s protocols (incubation
time, temperature and buffer composition). The multiplex
immunoassay can be easily extended with other mycotoxins
of interest, but finding a suitable multi-mycotoxin cleanup
to remove matrix effects will improve its applicability.
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